Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
1
RXST Quote, Financials, Valuation and Earnings
Last price:
$33.64
Seasonality move
:
22.68%
Day range:
$33.03 - $36.20
52-week range:
$33.03 - $66.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
9.91x
P/B ratio:
4.89x
Volume:
2.2M
Avg. volume:
836K
1-year change:
-11.74%
Market cap:
$1.4B
Revenue:
$89.1M
EPS (TTM):
-$0.82
Earnings Data
Next earnings date for RXST
Feb 28
2025
Most recent earnings per share
-$0.16
Missed by $0.09
(Nov 7/2024)
Consensus Estimate
-$0.07
(Nov 7/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RXST Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/28/2025 | Q4 | $40.4M | -- | -- | -$0.02 | -- |
| 11/07/2024 | Q3 | $35.1M | $35.3M | -$0.16 | -$0.07 | -$0.09 |
| 08/05/2024 | Q2 | $32.1M | $34.9M | -$0.16 | -$0.11 | -$0.05 |
| 05/06/2024 | Q1 | $27.6M | $29.5M | -$0.25 | -$0.19 | -$0.06 |
| 02/28/2024 | Q4 | $27.9M | $28.6M | -$0.25 | -$0.27 | $0.02 |
| 11/09/2023 | Q3 | -- | -- | -$0.35 | -$0.35 | $0.00 |
| 08/07/2023 | Q2 | -- | -- | -$0.40 | -$0.39 | -$0.01 |
| 05/09/2023 | Q1 | -- | -- | -$0.42 | -$0.45 | $0.03 |
| 03/06/2023 | Q4 | -- | -- | -$0.56 | -$0.74 | $0.18 |
| 11/07/2022 | Q3 | -- | -- | -$0.61 | -$0.68 | $0.07 |
| 08/08/2022 | Q2 | -- | -- | -$0.61 | -$0.65 | $0.04 |
| 05/05/2022 | Q1 | -- | -- | -$0.64 | -- | -- |
| 03/08/2022 | Q4 | -- | -- | -$0.58 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.68 | -- | -- |
| 09/07/2021 | Q2 | -- | -- | -$0.51 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.36 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | $0.96 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | $0.31 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.89 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$1.09 | -- | -- |
RxSight Earnings Questions
-
How Much did RxSight Generate in Revenue Last Quarter?
RxSight reported $35.3M worth of top line sales in its most recent quarter.
-
Did RxSight Beat Earnings Last Quarter?
RxSight announced earnings per share of -$0.16 which represents a miss of analyst forecast a -$0.07 per share.
-
Is RxSight Profitable?
RxSight reported $25.2M that represents $0.63 per share over the last quarter.
-
What is the Analyst Consensus for RxSight EPS Next Year?
RxSight's earnings are forecast to decrease from -$1.41 per share to -$1.05 per share next year representing a decrease of -93.76%.
-
When is RxSight's Earnings Date?
RxSight's next earnings date is February 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
